Apply

Ready to go for it?

AI Apply speeds things up—apply directly if you prefer.

FREE ACCESS
5,000–10,000 jobs/day
Scoutfield Logo

See all jobs on Scoutfield

Search thousands of fresh jobs every day.

Discover
  • Fresh listings
  • Fast filters
  • No subscription required
Create a free account and start exploring right away.
Verastem Oncology

Senior Medical Director, Clinical Development

Verastem Oncology

. Provide medical and scientific leadership for late-phase solid tumor clinical development, focused on the VS-7375 KRAS G12D ON/OFF inhibitor program .

Posted 10/27/2026full-timeBoston • Massachusetts • United StatesSenior💰 $320,000 - $350,000 per yearWebsite

Core Competencies

Role fit
Core Competencies

Use this summary to align your resume positioning with the role.

Demonstrates expertise in late-phase solid tumor clinical development, including trial design, medical monitoring, and regulatory submission processes. Possesses strong knowledge of Good Clinical Practice and the global drug development process, with a proven ability to interpret complex data and communicate effectively with stakeholders.

Highest-signal resume keywords
Medical Degree (MD)Oncology Clinical DevelopmentPhase 3 Pivotal TrialsGood Clinical Practice (GCP)NDA Submission Preparation

ATS Keywords

Tailor your resume
Applicant Tracking System Keywords

Tip: use these terms in your resume and cover letter to boost ATS matches.

Hard Skills
Trial DesignMedical MonitoringData InterpretationClinical Study ReportingBenefit-Risk AssessmentAdverse Event GradingRegulatory FilingClinical Query ResolutionSafety Signal ReviewResource Planning
Soft Skills
Interpersonal SkillsWritten CommunicationPresentation SkillsInfluencing SkillsCollaboration
Industry Keywords
BiotechnologyPharmaceutical IndustryOncologyFDA RequirementsEMA RequirementsRECISTSurvival EndpointsClinical OperationsClinical ScienceHealth Authority Interactions

About the role

Key responsibilities & impact
  • Provide medical and scientific leadership for late-phase solid tumor clinical development, focused on the VS-7375 KRAS G12D ON/OFF inhibitor program
  • Lead the medical aspects of assigned Phase 3 pivotal trials and oversee medical monitoring
  • Lead trial design and medical execution with Clinical Science, Clinical Operations, Biostatistics, Regulatory Affairs, and other study team members
  • Establish study plans, timelines, resource needs, and budget inputs; monitor milestones, identify risks, and resolve clinical issues
  • Serve as primary medical monitor and contact for assigned trials; respond to investigator inquiries and assess eligibility questions
  • Oversee internal and external medical monitoring, including CRO support; review safety, efficacy, laboratory, and protocol deviation data
  • Collaborate on adverse-event and safety-signal review, benefit-risk assessment, risk mitigation, and data monitoring committee activities
  • Support clinical data reviews, medical query resolution, interim analyses, database lock, and final reporting
  • Interpret efficacy, safety, pharmacology, and translational data to inform development and regulatory filing decisions
  • Author and review protocols, investigator brochures, informed consent forms, clinical study reports, and regulatory submission sections
  • Contribute to NDA and applicable MAA preparation and filing, including clinical summaries, benefit-risk assessments, integrated analyses, and responses to health authorities
  • Prepare briefing documents and clinical presentations, participate in agency interactions, and support inspection readiness
  • Build relationships with investigators, key opinion leaders, advisors, and stakeholders; lead presentations and contribute to scientific publications

Requirements

What you’ll need
  • Medical degree (MD or equivalent)
  • At least 5 years of biotechnology or pharmaceutical industry experience in oncology clinical development, including direct responsibility for late-phase solid tumor trials
  • Demonstrated experience in design, conduct, medical monitoring, and interpretation of Phase 3 pivotal studies, including trial delivery through key analyses and clinical study reporting
  • Hands-on experience contributing clinical content to at least one oncology marketing application (NDA or equivalent), including submission preparation and filing, with direct involvement in health authority interactions and responses to agency questions
  • Strong knowledge of Good Clinical Practice, the global drug development process, FDA and EMA requirements, and oncology efficacy and safety assessments, including RECIST, survival endpoints, and adverse event grading
  • Sound medical judgment and ability to interpret complex data, assess benefit-risk, resolve clinical issues, and communicate clear recommendations
  • Ability to work independently and collaboratively in a matrixed environment, manage competing priorities, and achieve clinical development milestones
  • Excellent interpersonal, written communication, presentation, and influencing skills
  • Ability to travel up to 25% of the time